H-1B sponsorship profile: Leap Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Leap Therapeutics Inc filed 4 Labor Condition Applications covering 4 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (4 certified of 4 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Leap Therapeutics Inc’s H-1B petitions range from $185,000 at the low end to $210,000 at the high end, with a petition-weighted average of $197,500. That range reflects the mix of occupations the company sponsors, led by Associate Director, PV Operations (2 petitions at $185,000 avg), followed by Director, Downstream Process Development and Manufacturing and Director, Biostatistics. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Leap Therapeutics Inc is headquartered in Cambridge, MA under NAICS code 54171, and places H-1B workers across 3 states, most heavily in MD, MA, PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Leap Therapeutics Inc ranks. By H-1B petition volume, Leap Therapeutics Inc is #30,742 of 119,880 employers nationally and #1,400 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.